- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
VRIO Analysis of Intelligent Medicine The Novartis-Proteus Alliance
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of Intelligent Medicine The Novartis-Proteus Alliance will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The Intelligent Medicine The Novartis-Proteus Alliance VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The Intelligent Medicine The Novartis-Proteus Alliance VRIO Analysis shows that the financial resources of Intelligent Medicine The Novartis-Proteus Alliance are highly valuable as these help in investing into external opportunities that arise. These also help Intelligent Medicine The Novartis-Proteus Alliance in combating external threats.
- According to the VRIO Analysis of Intelligent Medicine The Novartis-Proteus Alliance, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The Intelligent Medicine The Novartis-Proteus Alliance VRIO Analysis shows that Intelligent Medicine The Novartis-Proteus Alliance's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of Intelligent Medicine The Novartis-Proteus Alliance's products.
- According to the VRIO Analysis of Intelligent Medicine The Novartis-Proteus Alliance, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for Intelligent Medicine The Novartis-Proteus Alliance. These patents also provide Intelligent Medicine The Novartis-Proteus Alliance with licensing revenue when it licenses these patents out to other manufacturers.
- The Intelligent Medicine The Novartis-Proteus Alliance VRIO Analysis shows that Intelligent Medicine The Novartis-Proteus Alliance’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for Intelligent Medicine The Novartis-Proteus Alliance. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of Intelligent Medicine The Novartis-Proteus Alliance, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The Intelligent Medicine The Novartis-Proteus Alliance VRIO Analysis shows that the research and development at Intelligent Medicine The Novartis-Proteus Alliance is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for Intelligent Medicine The Novartis-Proteus Alliance. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of Intelligent Medicine The Novartis-Proteus Alliance are found to be rare according to the VRIO Analysis of Intelligent Medicine The Novartis-Proteus Alliance. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by Intelligent Medicine The Novartis-Proteus Alliance VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as Intelligent Medicine The Novartis-Proteus Alliance and inhibit competitive advantage. This means that the local food products result in competitive parity for Intelligent Medicine The Novartis-Proteus Alliance. As this resource is valuable, Intelligent Medicine The Novartis-Proteus Alliance can still make use of this resource.
- The employees of Intelligent Medicine The Novartis-Proteus Alliance are a rare resource as identified by the VRIO Analysis of Intelligent Medicine The Novartis-Proteus Alliance. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of Intelligent Medicine The Novartis-Proteus Alliance are a rare resource as identified by the Intelligent Medicine The Novartis-Proteus Alliance VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows Intelligent Medicine The Novartis-Proteus Alliance to use them without interference from the competition.
- The distribution network of Intelligent Medicine The Novartis-Proteus Alliance is a rare resource as identified by the VRIO Analysis of Intelligent Medicine The Novartis-Proteus Alliance. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of Intelligent Medicine The Novartis-Proteus Alliance. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of Intelligent Medicine The Novartis-Proteus Alliance are costly to imitate as identified by the Intelligent Medicine The Novartis-Proteus Alliance VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of Intelligent Medicine The Novartis-Proteus Alliance. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by Intelligent Medicine The Novartis-Proteus Alliance provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of Intelligent Medicine The Novartis-Proteus Alliance are also not costly to imitate as identified by the Intelligent Medicine The Novartis-Proteus Alliance VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from Intelligent Medicine The Novartis-Proteus Alliance by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of Intelligent Medicine The Novartis-Proteus Alliance a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of Intelligent Medicine The Novartis-Proteus Alliance are very difficult to imitate as identified by the VRIO Analysis of Intelligent Medicine The Novartis-Proteus Alliance. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of Intelligent Medicine The Novartis-Proteus Alliance is also very costly to imitate by competition as identified by the Intelligent Medicine The Novartis-Proteus Alliance VRIO Analysis. This has been developed over the years gradually by Intelligent Medicine The Novartis-Proteus Alliance. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of Intelligent Medicine The Novartis-Proteus Alliance are organised to capture value as identified by the VRIO Analysis of Intelligent Medicine The Novartis-Proteus Alliance. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for Intelligent Medicine The Novartis-Proteus Alliance.
- The Patents of Intelligent Medicine The Novartis-Proteus Alliance are not well organised as identified by the Intelligent Medicine The Novartis-Proteus Alliance VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if Intelligent Medicine The Novartis-Proteus Alliance starts selling patented products before the patents expire.
- The distribution network of Intelligent Medicine The Novartis-Proteus Alliance is organised as identified by the VRIO Analysis of Intelligent Medicine The Novartis-Proteus Alliance. Intelligent Medicine The Novartis-Proteus Alliance uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for Intelligent Medicine The Novartis-Proteus Alliance.
From the VRIO Analysis of Intelligent Medicine The Novartis-Proteus Alliance, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of Intelligent Medicine The Novartis-Proteus Alliance is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Li Na
4.0
Want to express my feelings about the friendly and kind attitude of the writer. I admire your receptivity to your work.
Alice Benjamin
5.0
The professor awarded me A score in the document because the paper was close to his opinion. I'm sad about my friends because some of them got C and one got D. Actually, I got assistance from this service at the last hour and didn't share about it with them.
Cameron
5.0
This service works perfectly fine and thanks you for the reasonable prices. They are efficient people and easy to use.
Brian Adam
5.0
This service is really convenient and reliable. These guys solved my paper in no time. Highly recommended service for all who need quick help. Thank you so much!
Next Articles
- The Alaskan Gold Mine Vrio Analysis
- TenAlpina Tools: The Entrepreneur's Dilemma Vrio Analysis
- Miraclefeet.org: Fundraising And Financial Sustainability Vrio Analysis
- Hyperloop One Vrio Analysis
- Finding A Niche In The Global Software Marketplace: The Case Of The Peruvian Firm LOLIMSA, Technologias Para Salud Vrio Analysis
- A Note On Rights Vrio Analysis
- Primo Benzina AG, Spanish Version Vrio Analysis
- Hydro Quebec And The Great Whale Project Vrio Analysis
- How To Build Collaborative Advantage Vrio Analysis
- How Storytelling Builds Next Generation Leaders Vrio Analysis
Previous Articles
- Note On Customer Care And Service Vrio Analysis
- BRAC: Shasthya Shebikas' Role In Delivering Health Care Service To Rural Markets Vrio Analysis
- Board Crisis Simulation (BCS) (B): Profiles Vrio Analysis
- SAP Design Thinking, Part A Vrio Analysis
- AccorHotels' Digital Transformation: A Response To Hospitality Disruptor Airbnb Vrio Analysis
- Lessons From Movement Makers: What Social Upheaval Teaches Us About Engagement Vrio Analysis
- Unlocking Value At Canadian Pacific: The Proxy Battle With Pershing Square Vrio Analysis
- Cosan: Thinking Outside The Barrel Vrio Analysis
- The Basics Of Private Equity Funds Vrio Analysis
- Nuclear Tube Assembly Room (A) (Condensed) Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!